{"name":"Pontificia Universidad Catolica de Chile","slug":"pontificia-universidad-catolica-de-chile","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":14,"colorKey":"oncology","drugs":[{"name":"Artificial Saliva","genericName":"Artificial Saliva","slug":"artificial-saliva","indication":"Other","status":"marketed"},{"name":"Tamsulosin Hydrochloride 0.4 milligrams","genericName":"Tamsulosin Hydrochloride 0.4 milligrams","slug":"tamsulosin-hydrochloride-0-4-milligrams","indication":"Benign prostatic hyperplasia with lower urinary tract symptoms","status":"marketed"},{"name":"5% sildenafil cream","genericName":"5% sildenafil cream","slug":"5-sildenafil-cream","indication":"Other","status":"phase_1"},{"name":"H-Bupivacaine","genericName":"H-Bupivacaine","slug":"h-bupivacaine","indication":"Other","status":"marketed"},{"name":"Intraoperative","genericName":"Intraoperative","slug":"intraoperative","indication":"Other","status":"phase_2"},{"name":"Levobupivacaine 10 mL","genericName":"Levobupivacaine 10 mL","slug":"levobupivacaine-10-ml","indication":"Other","status":"marketed"},{"name":"Levobupivacaine 25 mL","genericName":"Levobupivacaine 25 mL","slug":"levobupivacaine-25-ml","indication":"Other","status":"marketed"},{"name":"Levobupivacaine with epinephrine","genericName":"Levobupivacaine with epinephrine","slug":"levobupivacaine-with-epinephrine","indication":"Local and regional anesthesia for surgical and diagnostic procedures","status":"marketed"},{"name":"Levobupivacaine without epinephrine","genericName":"Levobupivacaine without epinephrine","slug":"levobupivacaine-without-epinephrine","indication":"Local and regional anesthesia for surgical procedures","status":"marketed"},{"name":"Methadone Injectable Product","genericName":"Methadone Injectable Product","slug":"methadone-injectable-product","indication":"Other","status":"marketed"},{"name":"N-acetylcysteine 1000 mg","genericName":"N-acetylcysteine 1000 mg","slug":"n-acetylcysteine-1000-mg","indication":"Other","status":"marketed"},{"name":"N-acetylcysteine 500 mg","genericName":"N-acetylcysteine 500 mg","slug":"n-acetylcysteine-500-mg","indication":"Other","status":"marketed"},{"name":"Vasopressor test","genericName":"Vasopressor test","slug":"vasopressor-test","indication":"Other","status":"phase_1"},{"name":"Water (Placebo)","genericName":"Water (Placebo)","slug":"water-placebo","indication":"Control/comparator in clinical research studies","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Autologous Serum 50%","genericName":"Autologous Serum 50%","slug":"autologous-serum-50","indication":"Dry eye syndrome / Ocular surface disease","status":"phase_3"},{"name":"Autologous Serum 20%","genericName":"Autologous Serum 20%","slug":"autologous-serum-20","indication":"Severe dry eye syndrome","status":"phase_3"},{"name":"Cyclopentolate+tropicamide+phenylephrine","genericName":"Cyclopentolate+tropicamide+phenylephrine","slug":"cyclopentolate-tropicamide-phenylephrine","indication":"Mydriasis and cycloplegia for ophthalmic examination and diagnostic procedures","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Post-operative","genericName":"Post-operative","slug":"post-operative","indication":"Post-operative pain management","status":"marketed"},{"name":"Topical 2,5% lidocaine + 2,5% prilocaine gel","genericName":"Topical 2,5% lidocaine + 2,5% prilocaine gel","slug":"topical-2-5-lidocaine-2-5-prilocaine-gel","indication":"Topical treatment of pain associated with minor cuts, scrapes, and burns","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Hepatitis B recombinant vaccine","genericName":"Hepatitis B recombinant vaccine","slug":"hepatitis-b-recombinant-vaccine","indication":"Prevention of hepatitis B virus infection in unvaccinated or non-immune individuals","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Optimized bismuth quadruple therapy","genericName":"Optimized bismuth quadruple therapy","slug":"optimized-bismuth-quadruple-therapy","indication":"Helicobacter pylori infection eradication","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Tretinoin 0.05%","genericName":"Tretinoin 0.05%","slug":"tretinoin-0-05","indication":"Acne vulgaris","status":"marketed"}]}],"pipeline":[{"name":"Artificial Saliva","genericName":"Artificial Saliva","slug":"artificial-saliva","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Autologous Serum 50%","genericName":"Autologous Serum 50%","slug":"autologous-serum-50","phase":"phase_3","mechanism":"Autologous serum 50% is a patient's own blood serum diluted to 50% concentration, applied topically to provide growth factors and immunomodulatory components for tissue repair and healing.","indications":["Dry eye syndrome / Ocular surface disease","Corneal epithelial defects"],"catalyst":""},{"name":"Tamsulosin Hydrochloride 0.4 milligrams","genericName":"Tamsulosin Hydrochloride 0.4 milligrams","slug":"tamsulosin-hydrochloride-0-4-milligrams","phase":"marketed","mechanism":"Tamsulosin selectively blocks alpha-1A adrenergic receptors in the prostate and bladder neck, relaxing smooth muscle to improve urine flow.","indications":["Benign prostatic hyperplasia with lower urinary tract symptoms"],"catalyst":""},{"name":"5% sildenafil cream","genericName":"5% sildenafil cream","slug":"5-sildenafil-cream","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Autologous Serum 20%","genericName":"Autologous Serum 20%","slug":"autologous-serum-20","phase":"phase_3","mechanism":"Autologous serum 20% is a topical ophthalmic preparation of the patient's own blood serum that provides growth factors and immunomodulatory components to promote corneal healing and reduce ocular surface inflammation.","indications":["Severe dry eye syndrome","Corneal epithelial defects","Ocular surface disease"],"catalyst":""},{"name":"Cyclopentolate+tropicamide+phenylephrine","genericName":"Cyclopentolate+tropicamide+phenylephrine","slug":"cyclopentolate-tropicamide-phenylephrine","phase":"marketed","mechanism":"This combination of three anticholinergic and sympathomimetic agents dilates the pupil and paralyzes accommodation for ophthalmic examination.","indications":["Mydriasis and cycloplegia for ophthalmic examination and diagnostic procedures"],"catalyst":""},{"name":"H-Bupivacaine","genericName":"H-Bupivacaine","slug":"h-bupivacaine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hepatitis B recombinant vaccine","genericName":"Hepatitis B recombinant vaccine","slug":"hepatitis-b-recombinant-vaccine","phase":"marketed","mechanism":"This recombinant vaccine stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.","indications":["Prevention of hepatitis B virus infection in unvaccinated or non-immune individuals"],"catalyst":""},{"name":"Intraoperative","genericName":"Intraoperative","slug":"intraoperative","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Levobupivacaine 10 mL","genericName":"Levobupivacaine 10 mL","slug":"levobupivacaine-10-ml","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Levobupivacaine 25 mL","genericName":"Levobupivacaine 25 mL","slug":"levobupivacaine-25-ml","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Levobupivacaine with epinephrine","genericName":"Levobupivacaine with epinephrine","slug":"levobupivacaine-with-epinephrine","phase":"marketed","mechanism":"Levobupivacaine blocks sodium channels in nerve cell membranes to produce local anesthesia, while epinephrine causes vasoconstriction to prolong the anesthetic effect and reduce systemic absorption.","indications":["Local and regional anesthesia for surgical and diagnostic procedures","Infiltration anesthesia","Nerve blocks"],"catalyst":""},{"name":"Levobupivacaine without epinephrine","genericName":"Levobupivacaine without epinephrine","slug":"levobupivacaine-without-epinephrine","phase":"marketed","mechanism":"Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.","indications":["Local and regional anesthesia for surgical procedures","Infiltration anesthesia","Nerve blocks","Epidural anesthesia"],"catalyst":""},{"name":"Methadone Injectable Product","genericName":"Methadone Injectable Product","slug":"methadone-injectable-product","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"N-acetylcysteine 1000 mg","genericName":"N-acetylcysteine 1000 mg","slug":"n-acetylcysteine-1000-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"N-acetylcysteine 500 mg","genericName":"N-acetylcysteine 500 mg","slug":"n-acetylcysteine-500-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Optimized bismuth quadruple therapy","genericName":"Optimized bismuth quadruple therapy","slug":"optimized-bismuth-quadruple-therapy","phase":"marketed","mechanism":"Bismuth quadruple therapy combines bismuth subsalicylate with three antimicrobial agents to eradicate Helicobacter pylori infection through multiple mechanisms of action.","indications":["Helicobacter pylori infection eradication"],"catalyst":""},{"name":"Post-operative","genericName":"Post-operative","slug":"post-operative","phase":"marketed","mechanism":"This drug works by inhibiting the action of certain neurotransmitters in the brain.","indications":["Post-operative pain management"],"catalyst":""},{"name":"Topical 2,5% lidocaine + 2,5% prilocaine gel","genericName":"Topical 2,5% lidocaine + 2,5% prilocaine gel","slug":"topical-2-5-lidocaine-2-5-prilocaine-gel","phase":"phase_3","mechanism":"Lidocaine and prilocaine work by blocking the action of sodium channels in nerve cells, preventing the transmission of pain signals.","indications":["Topical treatment of pain associated with minor cuts, scrapes, and burns"],"catalyst":""},{"name":"Tretinoin 0.05%","genericName":"Tretinoin 0.05%","slug":"tretinoin-0-05","phase":"marketed","mechanism":"Tretinoin is a retinoid that binds to retinoic acid receptors to regulate gene expression, promoting cell differentiation and reducing sebum production and comedone formation.","indications":["Acne vulgaris","Photoaged skin and wrinkles","Keratosis pilaris"],"catalyst":""},{"name":"Vasopressor test","genericName":"Vasopressor test","slug":"vasopressor-test","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Water (Placebo)","genericName":"Water (Placebo)","slug":"water-placebo","phase":"marketed","mechanism":"Water acts as an inert placebo with no active pharmacological mechanism.","indications":["Control/comparator in clinical research studies"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNcmNHZ0RNeTJRY2Y5b2JLMzRzRmZ6aXQ2ajQwUmNjV3EtNkZiUndHUUMtSlctS3lWN3dmWW91OHFoaWYtSEdySW0xLUJWdk1ZQko3SzEzaWJlVExwQk5DMVBKWWJhbGQzR3JOb21CMm42SGFiZ0Y4LXRBT0o2bVdqLS1vUTE4U2FPMERWcWJTbzlIYWV0T3RuRG9YVmhUa2RaMlpWR09Hck54ejZwelJjaWs4SXdlbUZjZ1hXeWFmR1ZLd0d4WEdmM2tnMnJKREpuWkFUdVdnMkRmQW1aVDBIeHlKXzhILUduR09EOVhXNUcwc3FIZzZDd9IB_gFBVV95cUxQVkV4UTNURWFwTk5vRkhNVDJfYWg4Z0JNd1JZNXJjclpNRDV0RllxWHc3aWFNRjZ4eFgyd1A2aUEtMThCX1JGcnI4QTF3MlAyc25selZYTmlpQ0Z0WXNGeXdFTW9GZFc0dmhla1dkWGsteTRmVTlJLVplc0luaFBTRXFIdEMxckE3SHdGQjlwY1A4Yks1NENkdzdHOXFhanRmWHJVZWM2aWhnTW12SU1EQVlnUWs1VnJ2N0stOXlHaHlvYTc2WHA1ODdmUVI2UURlb2VLb1RGQnp2NVZPZjVmbFNpaGNiSi1ZUFZkaGlGbUdfQ3E0UVNmWDVtQ3djdw?oc=5","date":"2026-02-19","type":"regulatory","source":"Business Standard","summary":"Alembic Pharma slumps after receiving two USFDA observations for karakhadi facility - Business Standard","headline":"Alembic Pharma slumps after receiving two USFDA observations for karakhadi facility","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"pipeline","source":"Careers360","summary":"UP Polytechnic JEECUP 2026 exam dates out for engineering, pharma; registration from January 15 - Careers360","headline":"UP Polytechnic JEECUP 2026 exam dates out for engineering, pharma; registration from January 15 - Careers360","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-17","type":"pipeline","source":"Careers360","summary":"Maharashtra pharmacy colleges struggle to fill seats; 15,936 BPharm, 815 MPharm seats vacant after last round - Careers360","headline":"Maharashtra pharmacy colleges struggle to fill seats; 15,936 BPharm, 815 MPharm seats vacant after last round - Careers3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNTlg5SllZVms0X1NkajU2RVRHcUZ2aUM2cDNEN2tTS1JvSlNfTUh0OFpEd0JmZ3hYTVMtN2Z6NlhUX0I2M2JUcWVFRWFCQ3EyZUVqYVJTcWZyOWFQSXNDZ1kzMncwYVk2ZHNTMm5jcVB6NFRfV0Z1SmIzVHV5TG15aVZPOXFHcjRfYUFPQmtXcGVBVTZwYlI5R29KOE01d3RTazhoaENSWDRmVnJPTXB4MWFMREp1bWY5ZDAyU3UyNVMza1I4LW5HLXRzT0JreEczMG5oU2RlWjF6ZUw5RG90R21OSEhZUdIB6wFBVV95cUxOYlVnckhVTDZrMmU0MUx1VTY5RUY0R3I3WVpfWDFIWlpBclFYaWtzTm04NWRoYndRX3pYUHV1akJwWkhobDRFOThlT19JcXpJenU2NTAwQkZ6TWUtM1owR2o0dl9MNXRUU0hyRzk3Si1Wc3loTWVaZkFlX2EycS1kTS03NTBSbklQOWFXdTM5TXk2ZnNEbWFsQlIyN3J2dGtKMkZfQlg1OW9LS0xMcVplaGFKcUUzb0ZSU05xc0Z2bEUwNC1nbVMtUERxUjFjSGUxUXd3WXhKQWdLT3oyNGZCZ1NUMmQwQ19fV3pr?oc=5","date":"2025-10-23","type":"pipeline","source":"Business Standard","summary":"Aurobindo Pharma gains after arm incorporates new subsidiary in Chile - Business Standard","headline":"Aurobindo Pharma gains after arm incorporates new subsidiary in Chile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQY3o0Qk9zdmxraW1GcFkzeFl5elZJa3JsVjlsU0h4TlBLd3FiaURDZFFEZ1VHTTQ1bjhlNmI3aVhLMFQ4X2x0WFRvbjY0cUpHSjFBOEVNekVCQkhlNkdCSmVaOENRTGNxU20weUFQcFo1Rm1xQlRmQ2RzeHpvc0l3b0M1YlJwTzdsczJrN2JlZzdhbC0xZG9WV1NNSmxkVEpwT3p0V00yN2YtNFdSZGxrTC1PMTZhc0R6ZFhSUnNTRlhtS2tDbHdkcGZ2Zw?oc=5","date":"2025-10-21","type":"pipeline","source":"Jagran Josh","summary":"TS PGECET 2025: M.Pharmacy Seat Allotment Result OUT at pgecetadm.tgche.ac.in, Direct Link Here - Jagran Josh","headline":"TS PGECET 2025: M.Pharmacy Seat Allotment Result OUT at pgecetadm.tgche.ac.in, Direct Link Here","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFA3TUdDNWltajFBd3pJY29MNi1lZGV2OWFOOEg3ZWg0bHV1RnV1UGJTclJjZUFBX1A0b2N1M1RpRlRKbWFZaVB3OXZ3TTVzcDJBbnA4OGZacFAwN2xpRFpieWpZcWp4Vm1nOUQzc2lwc0hWdGo0ZURZaGtKdG0zZw?oc=5","date":"2025-09-04","type":"pipeline","source":"Physics Wallah","summary":"BEML Limited Pharmacist Recruitment 2025, Notification, Last Date to Apply 12 Sep - Physics Wallah","headline":"BEML Limited Pharmacist Recruitment 2025, Notification, Last Date to Apply 12 Sep","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-04","type":"pipeline","source":"Careers360","summary":"NIRF Ranking 2025 Pharmacy: Jamia Hamdard still best, BITS Pilani replaces NIPER Hyderabad in second place - Careers360","headline":"NIRF Ranking 2025 Pharmacy: Jamia Hamdard still best, BITS Pilani replaces NIPER Hyderabad in second place - Careers360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNdmJSTlJrOXJmcS1heHFmNEQwV0FYeWt2cVYtRHQ5Q0pLQkVHNzBVa0x1R3R2R0NhenZocGtZWUdrLTh0QjNsMUlTYXJfYmg1SlpMeU9fRHNmZmRvRmZqWHJYVms1X0ZNcUZ5d0xjUGQ3dHdLNG5yeVFvcTdQSmprM2J0U0dMamVHMEVHRkpSN2V0OWZSUEtXM09rd1FMd9IBqwFBVV95cUxOeGtNUmdUU2V6Y3dsQlhBZzVFb0VtYWFRUDdybnJPd3l2c3VPZFpaZjlsZWd4SnhPSk1TWi1IMlo0WHBmMVRBUzBNSGV4eEhxbzkxQUxHYUtKV1V1azFPQkEtV2p3dnBhYlp4Ykt0M0kyVmVOODFwMHIxeWtWcmR0eEVUY3RHd3pnODlmNmlnd21XQnAyV1I4RDI0TDNQLU5xZS1mVGZCNUg0YlU?oc=5","date":"2025-05-25","type":"pipeline","source":"The New Indian Express","summary":"CBSE students dominate KCET results - The New Indian Express","headline":"CBSE students dominate KCET results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOUVdiZ2czQ3JOZGZiVnd4Q0hrSU9iUERfYkt1d19wbXEwNzk5bkhaeERpbU5KVTVpN0N1LWIwMC1LOFdDTDNWOHpfVHVLaHlxcTVoQXdIanhXWVAtdjVwdDJFQk9ib01FakZYNklZWUNZaTVJSGxKTl9NcTF1ZnEtR1JWYm9UbkJVME15OHRzaU9qN0VWazMwWTN4VzBuUU5YNXRyNkxxMVNfd9IBsAFBVV95cUxOMkNuVG1EbkJnTkY5TmNNTzhTUXJ5bnJGbEN4dTc1XzhwWUdoV3JVM3J3clNlbjVxRmRuQmZTOWh0TVBhbFVkdlphX1h0MGh1OE9rTjcybW9jRVVvV0l6M0pwZ2d1cU13QjdOaEU0UmFEcW1xTUlpNGhJRGtLYkFJWlZZTmVVZGJrZVVOMWxBNWVfWHA0QUZmeXFMQ1MyUHpoeDZLN0xNZXYxbC01cEY4Wg?oc=5","date":"2025-05-24","type":"pipeline","source":"The Hindu","summary":"CBSE students dominate KCET top ranks - The Hindu","headline":"CBSE students dominate KCET top ranks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1tVENRcTQ4N3NidzZDVzV0QVctdEh5YWdqb3pNMFpMWk9EcnBiaWxPdThnRmNHVlBtZm1PU1g0WmQ1bFJnTEs1MUVnYkhXM1c0UE9vanJOQ19wRHhGSkg3VA?oc=5","date":"2025-03-16","type":"pipeline","source":"Physics Wallah","summary":"KCET Pharmacy 2025, Exam Date Released, Eligibility, Pattern - Physics Wallah","headline":"KCET Pharmacy 2025, Exam Date Released, Eligibility, Pattern","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2TUZmV3p3S3NiVjRsdUdnd1BCcXZIMld0MDJJZE12V3JTWVVzOEpGdVV3ZFNrNGVJdkYwc2ZoSlB4QktNRWoza3FoLUVPaUtrMEJMSU95QWtBTkFlYjBN?oc=5","date":"2025-03-11","type":"pipeline","source":"Nature","summary":"Novel 5-HT6R modulators as mTOR-dependent neuronal autophagy inductors | Scientific Reports - Nature","headline":"Novel 5-HT6R modulators as mTOR-dependent neuronal autophagy inductors | Scientific Reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQUXJyVHhqYUlNbGRCVExxYUtyeXlIQTR0SmlXMmo5Y1YtbXBNZXhaSWRtTWhDbk4ya014Qmh1dDUtNTBpaFV0bXhicWFZOUNMTDM1cWliTWVUM0s4R2x4SzlyRHNYcmZ0QUFQdlJVQjNjWm9heTYyLVljMUJ1WmRxZDhwWVBrQQ?oc=5","date":"2020-06-28","type":"pipeline","source":"Proactive financial news","summary":"Pancontinental Resources Corporation Share Price - PUC, RNS News, Articles, Quotes, & Charts (CVE:PUC) - Proactive financial news","headline":"Pancontinental Resources Corporation Share Price - PUC, RNS News, Articles, Quotes, & Charts (CVE:PUC)","sentiment":"neutral"}],"patents":[],"drugCount":22,"phaseCounts":{"marketed":16,"phase_3":3,"phase_1":2,"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}